CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,915 | +16.9% | 106,984 | -4.5% | 0.00% | +33.3% |
| Q2 2023 | $2,493 | -8.3% | 112,046 | -10.7% | 0.00% | -25.0% |
| Q1 2023 | $2,718 | +62.6% | 125,476 | +52.4% | 0.00% | +100.0% |
| Q4 2022 | $1,672 | -99.9% | 82,335 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $2,111,000 | +1.1% | 82,335 | -6.2% | 0.00% | 0.0% |
| Q2 2022 | $2,087,000 | -2.1% | 87,751 | -7.3% | 0.00% | +50.0% |
| Q1 2022 | $2,132,000 | +9.4% | 94,686 | -3.8% | 0.00% | 0.0% |
| Q4 2021 | $1,949,000 | +0.4% | 98,440 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $1,942,000 | -17.2% | 98,691 | -7.5% | 0.00% | 0.0% |
| Q2 2021 | $2,346,000 | -13.8% | 106,655 | -6.8% | 0.00% | -33.3% |
| Q1 2021 | $2,722,000 | -9.1% | 114,436 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,994,000 | +55.6% | 114,436 | +3.5% | 0.00% | +50.0% |
| Q3 2020 | $1,924,000 | +10.1% | 110,536 | +6.3% | 0.00% | 0.0% |
| Q2 2020 | $1,748,000 | +70.9% | 103,946 | +20.9% | 0.00% | 0.0% |
| Q1 2020 | $1,023,000 | -1.7% | 86,000 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $1,041,000 | -28.8% | 86,000 | -16.9% | 0.00% | -50.0% |
| Q3 2019 | $1,463,000 | -2.9% | 103,500 | -23.4% | 0.00% | 0.0% |
| Q2 2019 | $1,506,000 | +17.9% | 135,084 | +24.2% | 0.00% | 0.0% |
| Q1 2019 | $1,277,000 | -0.2% | 108,735 | +13.5% | 0.00% | 0.0% |
| Q4 2018 | $1,280,000 | -16.0% | 95,800 | -11.8% | 0.00% | 0.0% |
| Q3 2018 | $1,523,000 | -57.2% | 108,600 | -52.0% | 0.00% | -50.0% |
| Q2 2018 | $3,556,000 | +0.5% | 226,200 | +5.2% | 0.00% | 0.0% |
| Q1 2018 | $3,537,000 | -16.5% | 215,000 | -8.3% | 0.00% | -20.0% |
| Q4 2017 | $4,235,000 | +125.3% | 234,500 | +140.8% | 0.01% | +150.0% |
| Q3 2017 | $1,880,000 | +63.6% | 97,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,149,000 | +37.3% | 97,400 | +27.5% | 0.00% | +100.0% |
| Q1 2017 | $837,000 | +50.8% | 76,401 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $555,000 | +11.7% | 76,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $497,000 | +19.2% | 76,400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $417,000 | +58.0% | 76,400 | +35.5% | 0.00% | – |
| Q1 2016 | $264,000 | -6.0% | 56,400 | 0.0% | 0.00% | – |
| Q4 2015 | $281,000 | +32.5% | 56,400 | 0.0% | 0.00% | – |
| Q3 2015 | $212,000 | -42.5% | 56,400 | -8.0% | 0.00% | -100.0% |
| Q2 2015 | $369,000 | – | 61,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |